A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.

Xue, Yuanbo; Li, Jing; Lu, Xiubo

Xue, Yuanbo; Li, Jing; Lu, Xiubo.

Affiliation

Xue Y; The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, Henan, P.R. China.
Li J; The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, Henan, P.R. China.
Lu X; The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, Henan, P.R. China.

Technol Cancer Res Treat ; 19: 1533033820935860, 2020.

Article in En | MEDLINE | ID: mdl-32588760

Subject(s)

Biomarkers, Tumor/genetics; Biomarkers, Tumor/immunology; Gene Expression Regulation, Neoplastic; Lymphocytes, Tumor-Infiltrating/immunology; Thyroid Neoplasms/pathology; Case-Control Studies; Female; Follow-Up Studies; Gene Expression Profiling; Humans; Male; Middle Aged; Prognosis; ROC Curve; Survival Rate; Thyroid Neoplasms/genetics; Thyroid Neoplasms/immunology; Transcriptome

Key words

cancer; immune-associated genes; prognostic signature; thyroid carcinoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Biomarkers, Tumor / Gene Expression Regulation, Neoplastic / Lymphocytes, Tumor-Infiltrating Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Technol Cancer Res Treat Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2020 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google